Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial

BACKGROUND: Bronchopulmonary dysplasia (BPD), an inflammatory-mediated chronic lung disease, is common in extremely preterm infants born before 28 weeks’ gestation and is associated with an increased risk of adverse neurodevelopmental and respiratory outcomes in childhood. Effective and safe prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Manley, Brett J., Kamlin, C. Omar F., Donath, Susan, Huang, Li, Birch, Pita, Cheong, Jeanie L. Y., Dargaville, Peter A., Dawson, Jennifer A., Doyle, Lex W., Jacobs, Susan E., Wilson, Rodney, Davis, Peter G., McKinlay, Christopher J. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169381/
https://www.ncbi.nlm.nih.gov/pubmed/37161488
http://dx.doi.org/10.1186/s13063-023-07257-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169381/
https://www.ncbi.nlm.nih.gov/pubmed/37161488
http://dx.doi.org/10.1186/s13063-023-07257-5

Ejemplares similares